Biosante Pharmaceuticals (BPAX)

Add to Watchlists Create an Alert
1.15 +0.01  +0.88%   NASDAQ May 23, 4:59PM BATS Real time Currency in USD

Biosante Pharmaceuticals Revenue TTM:

2.301M for Dec. 31, 2012
View Full Chart

Biosante Pharmaceuticals Revenue TTM Chart

    Biosante Pharmaceuticals Historical Revenue TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 2.301M
    Sept. 30, 2012 0.4475M
    June 30, 2012 0.5199M
    March 31, 2012 0.4922M
    Dec. 31, 2011 0.4352M
    Sept. 30, 2011 0.4638M
    June 30, 2011 0.3324M
    March 31, 2011 0.2514M
    Dec. 31, 2010 2.474M
    Sept. 30, 2010 3.395M
    June 30, 2010 3.354M
    March 31, 2010 3.470M
    Dec. 31, 2009 1.258M
    Sept. 30, 2009 3.804M
    June 30, 2009 3.876M
    March 31, 2009 3.786M
    Dec. 31, 2008 3.763M
    Sept. 30, 2008 0.4829M
    June 30, 2008 0.4445M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Revenues (TTM)

    Definition: Revenues

    Learn More

    Get data for

    BPAX Revenue TTM Benchmarks

    Companies
    Repros Therapeutics 0.003M
    Teva Pharmaceutical Industries 20.12B
    Eli Lilly and Company 22.60B

    BPAX Revenue TTM Rankings

    Overall 41st percentile
    4663 of 8006
    Sector 31st percentile
    469 of 686 in Healthcare
    Industry 48th percentile
    128 of 248 in Biotechnology

    BPAX Revenue TTM Range, Past 5 Years

    Minimum 0.2514M Mar 2011
    Maximum 3.876M Jun 2009
    Average 1.861M